KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Non-Current Debt: 2017-2025

Historic Non-Current Debt for Aquestive Therapeutics (AQST) over the last 8 years, with Sep 2025 value amounting to $29.9 million.

  • Aquestive Therapeutics' Non-Current Debt fell 4.20% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year decrease of 4.20%. This contributed to the annual value of $32.5 million for FY2024, which is 18.15% up from last year.
  • Aquestive Therapeutics' Non-Current Debt amounted to $29.9 million in Q3 2025, which was down 5.98% from $31.8 million recorded in Q2 2025.
  • Over the past 5 years, Aquestive Therapeutics' Non-Current Debt peaked at $51.6 million during Q4 2021, and registered a low of $20.8 million during Q2 2023.
  • In the last 3 years, Aquestive Therapeutics' Non-Current Debt had a median value of $30.0 million in 2024 and averaged $29.6 million.
  • As far as peak fluctuations go, Aquestive Therapeutics' Non-Current Debt skyrocketed by 50.17% in 2021, and later tumbled by 52.53% in 2023.
  • Over the past 5 years, Aquestive Therapeutics' Non-Current Debt (Quarterly) stood at $51.6 million in 2021, then tumbled by 35.12% to $33.4 million in 2022, then fell by 17.76% to $27.5 million in 2023, then increased by 18.15% to $32.5 million in 2024, then declined by 4.20% to $29.9 million in 2025.
  • Its Non-Current Debt was $29.9 million in Q3 2025, compared to $31.8 million in Q2 2025 and $33.7 million in Q1 2025.